ASTRO 2022

ASTRO Annual Meeting 2022

23–26 October 2022 | San Antonio, Texas

The 64th ASTRO Annual Meeting will take place from the 23-26 October 2022 in San Antonio, Texas.

View all videos

Artificial Intelligence GU Cancer GI Cancer Gynecological Cancer

The use of artificial intelligence in clinical trials

Julian Hong • 31 Oct 2022

Applications of artificial intelligence in cancer care

James Zou • 25 Oct 2022

Advances in digital pathology and artificial intelligence for prostate cancer

Osama Mohamed • 25 Oct 2022

Latest updates in artificial intelligence research in oncology from ASTRO 2022

Julian Hong • 31 Oct 2022

Genomic determinants of response to TMT for patients with muscle-invasive bladder cancer

Sophia Kamran • 3 Nov 2022

Results of the Phase III SAKK 09/10 trial of biomarkers for prostate cancer

Alan Dal Pra • 27 Oct 2022

Real-world associations between PSA screening and metastatic prostate cancer incidence

Alex Bryant • 17 Oct 2022

Disparities in assessment of sexual function of men and women undergoing radiotherapy for GU cancers

Jamie Takayesu • 20 Oct 2022

Results of Phase II trial comparing TACE and SBRT for hepatocellular carcinoma

Alejandra Mendez Romero • 28 Oct 2022

Potential role of radiotherapy for liver cancer

Laura A. Dawson • 17 Oct 2022

Challenges and unmet needs of treating patients with hepatocellular carcinoma with radiotherapy

Alejandra Mendez Romero • 28 Oct 2022

Results from a Phase III study of sorafenib and SBRT for hepatocellular carcinoma

Laura A. Dawson • 17 Oct 2022

CALLA: Phase III study of durvalumab and chemoradiotherapy for cervical cancer

Jyoti Mayadev • 21 Oct 2022

Interim results from Phase II trial of atezolizumab and SBRT in cervical cancer

Kamran Ahmed • 19 Oct 2022

Improving assessment of sexual function in men and women undergoing radiotherapy for GU cancers

Jamie Takayesu • 20 Oct 2022

Unmet needs in radiotherapy for cervical cancer

Jyoti Mayadev • 21 Oct 2022